Celsense

BiotechnologySeries DPittsburgh, UScelsense.com

Latest round

Series D

Last raised

Feb 2012

Total raised

$6.2M

Investors

1

About Celsense

Based in the US, Celsense biotechnology company which offers novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells.

Who invested in Celsense

1 investor across 6 rounds

See all investors in Celsense

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Feb 17, 2012

    Amount

    $0.1M

    Investors

    Locked

  2. Series C

    Nov 2, 2010

    Amount

    $1.7M

    Investors

    Locked

  3. Series C

    Apr 30, 2010

    Amount

    $0.7M

    Investors

    Locked

  4. Series B

    Apr 10, 2008

    Amount

    $2.3M

    Investors

    Locked

  5. Series A

    Jul 31, 2007

    Amount

    $0.7M

    Investors

    Locked

  6. Series A

    Aug 24, 2006

    Amount

    $0.6M

    Investors

    Locked

Questions about Celsense

Who invested in Celsense?

Celsense has 1 investor on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Celsense raised?

Celsense has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Celsense last raise money?

Celsense's most recent round on record is a Series D, in Feb 2012.

What does Celsense do?

Based in the US, Celsense biotechnology company which offers novel MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells.

Where is Celsense headquartered?

Celsense is headquartered in Pittsburgh, US.

Which VCs invest in companies like Celsense?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Celsense's stage. Their profiles are linked below.

Raising like Celsense? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.